Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1

Franck Morceau, Michael Schnekenburger, Romain Blasius, Isabelle Buck, Mario Dicato, Marc Diederich*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Abstract

Up-regulation of tumor necrosis factor α (TNFα) is linked to solid tumors as well as to hematologic disorders including different forms of anemia and multiple myeloma. This cytokine was shown to contribute to inhibition of erythroid maturation mechanisms which are characterized by the expression of specific genes regulated by GATA-1 and NF-E2 transcription factors. Here, we assessed the inhibiting effect of TNFα on erythroid differentiation using K562 cells which can be chemically induced to differentiate towards the erythroid pathway by aclacinomycin A, an anthracyclin. Results show that induced hemoglobinization of K562 cells as well as γ-globin and erythropoietin receptor gene expression are decreased by TNFα via the inhibition of GATA-1 at its mRNA and protein expression level. Additionally, both constitutive and induced binding activity of GATA-1 is abolished and induced activation of a GATA-1 driven luciferase reporter construct is inhibited. Altogether, our results provide insight into the molecular mechanisms of inflammation-induced inhibition of erythroid differentiation.

Original languageEnglish
Pages (from-to)203-212
Number of pages10
JournalCancer Letters
Volume240
Issue number2
DOIs
Publication statusPublished - 28 Aug 2006
Externally publishedYes

Keywords

  • Aclacinomycin A
  • Erythroid
  • GATA-1
  • Inflammation
  • NF-E2

Fingerprint

Dive into the research topics of 'Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1'. Together they form a unique fingerprint.

Cite this